Sign in

CIK 0001655759

  • Accelerated filer

ARVINAS, INC.

Sign in to watch
Ticker
ARVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472566120
Phone
+1 203-535-1456
Business address
395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
Former names
ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
  1. 4 Open-market sale Chief Scientific Officer sold 1,701 shares at $47.05 ($80,032)
  2. 4 Grant or award Chief Accounting Officer acquired 5,750 shares (grant or award)
  3. 4 Exercise or conversion Chief Scientific Officer acquired 8,252 shares (option exercise)
  4. 4 Planned sale Chief Medical Officer sold 1,324 shares at $24.39 ($32,289)
  5. 4 Grant or award Director acquired 4,121 shares (grant or award)
  6. 4 Grant or award Director acquired 4,121 shares (grant or award)
  7. 4 Grant or award Director acquired 4,121 shares (grant or award)
  8. 4 Grant or award Director acquired 4,121 shares (grant or award)
  9. 4 Grant or award Director acquired 4,121 shares (grant or award)
  10. 4 Grant or award Director acquired 4,121 shares (grant or award)
  11. 4 Grant or award Director acquired 4,121 shares (grant or award)
  12. 4 Grant or award Director acquired 4,121 shares (grant or award)
  13. 4 Grant or award Director acquired 8,242 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Chief Scientific Officer sold 1,051 shares at $29.53 ($31,036)
  16. 4 Open-market sale President and CEO sold 5,878 shares at $29.53 ($173,577)
  17. 4 Open-market sale Chief Financial Officer sold 1,745 shares at $29.53 ($51,530)
  18. 4 Grant or award Chief Financial Officer acquired 19,125 shares (grant or award)
  19. 4 Grant or award Chief Medical Officer acquired 19,125 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 61,975 shares (grant or award)

Page 5 of 15 · 285 filings